Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
4.430
+0.180 (4.24%)
May 1, 2024, 10:06 AM EDT - Market closed

Envoy Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
8835532517
Market Cap Growth
--93.35%2.87%-
Enterprise Value
8332567540
PE Ratio
-1.18-1.18-33.43-48.47
PS Ratio
274.46112.022246.041669.15
PB Ratio
-20.09-20.09-14.71-11.51
P/FCF Ratio
-1.99-1.99-59.00-73.28
P/OCF Ratio
-2.01-2.01-60.46-74.60
EV/Sales Ratio
262.89100.452390.991741.27
EV/EBITDA Ratio
-1.07-1.07-35.76-62.74
EV/EBIT Ratio
-1.06-1.06-35.59-62.22
EV/FCF Ratio
-1.78-1.78-62.80-76.45
Debt / Equity Ratio
-0.32-0.32-0.95-0.52
Debt / EBITDA Ratio
-0.02-0.02-2.18-2.73
Debt / FCF Ratio
-0.03-0.03-3.83-3.32
Quick Ratio
0.670.670.090.87
Current Ratio
1.031.030.651.76
Asset Turnover
0.020.020.000.00
Return on Equity (ROE)
124.80%124.80%64.20%63.00%
Return on Assets (ROA)
-154.60%-154.60%-5.00%-3.30%
Return on Capital (ROIC)
1530.92%1530.92%524.46%31.98%
Earnings Yield
-34.48%-84.49%-2.99%-2.06%
FCF Yield
-20.53%-50.31%-1.70%-1.36%
Buyback Yield / Dilution
-24.00%-24.00%92.73%-
Total Shareholder Return
-24.00%-24.00%92.73%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).